Insulin analogs versus human insulin in type 2 diabetes

scientific article published on August 2011

Insulin analogs versus human insulin in type 2 diabetes is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0168-8227(11)70023-7
P698PubMed publication ID21864739

P2093author name stringIlias N Migdalis
P2860cites workLong-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitusQ24245192
Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitusQ33218080
Insulins today and beyondQ34365284
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesQ36449523
Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemirQ36682344
When basal insulin therapy in type 2 diabetes mellitus is not enough--what next?Q36742128
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.Q37250601
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?Q37364945
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetesQ42605636
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patientsQ44631767
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetesQ46406475
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 DiabetesQ59311920
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysisQ81317578
Long-acting insulin analogs versus human insulinsQ81805752
P921main subjecttype 2 diabetesQ3025883
preproinsulinQ7240673
P304page(s)S102-4
P577publication date2011-08-01
P1433published inDiabetes Research and Clinical PracticeQ15750054
P1476titleInsulin analogs versus human insulin in type 2 diabetes
P478volume93 Suppl 1

Reverse relations

cites work (P2860)
Q47191041Clinical characteristics of type 2 diabetes patients with discordance between HbA1c and fasting plasma glucose in the real world: an analysis of the ORBIT study
Q39077176Comparison of medication adherence in diabetes mellitus patients on human versus analogue insulins
Q39054758Comparison of the impact of human vs analogue insulins on glycosylated haemoglobin in a population with diabetes mellitus
Q33603478Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulin
Q36515474Long-acting basal insulin analogs: latest developments and clinical usefulness
Q38055517Novel non-invasive methods of insulin delivery